Show
Sort by
-
Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2) : phase 3, randomised, double-blind, parallel trials
-
- Journal Article
- A1
- open access
Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps : SYNAPSE 24‐week treatment‐free follow‐up
-
- Journal Article
- A1
- open access
EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care
-
- Journal Article
- A1
- open access
Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps
-
- Journal Article
- A1
- open access
Dupilumab demonstrates rapid onset of response across three type 2 inflammatory diseases
-
- Journal Article
- A1
- open access
Reducing fungal exposure critical for treating rhinosinusitis with or without polyps [response to letter]
-
- Journal Article
- A1
- open access
Burden of disease in chronic rhinosinusitis with nasal polyps
-
Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps
-
- Journal Article
- A1
- open access
Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma
-
International consensus statement on allergy and rhinology : rhinosinusitis 2021